Image

Circulating Microvesicles Regulating Metabolic Homeostasis in Obesity After Caloric Restriction Programs

Circulating Microvesicles Regulating Metabolic Homeostasis in Obesity After Caloric Restriction Programs

Recruiting
18-70 years
All
Phase N/A

Powered by AI

Overview

The main aim of the present study is to evaluate the effectiveness of two dietary protocols: Daily Caloric Restriction (DCR) and Early Time-Restricted Feeding + DCR (eTRE) on metabolic homeostasis and the influence of circulating extracellular vesicles (EVs) as inter-organ communication elements in obese patients.

Description

The specific objectives are:

  1. To assess the effect of two dietary protocols on weight loss and metabolic benefits in non-morbidly obese subjects.
  2. Influence of both protocols on energy signaling metabolites and the dynamics of enteroendocrine hormones.
  3. Define the "digital footprint" of EVs as inter-organ communication elements influencing metabolic status in obese subjects.

The study design comprises a randomized parallel-arm design (n=40) with consecutive 1:1 allocation to a calorie restriction protocol for a healthy Mediterranean diet under Daily Caloric Restriction (DCR) (n=20) or an eTRE protocol (n=20) for 12 weeks. Clinical and analytical variables, adherence, satiety, chronotype, and brown fat content will be determined before and at the end of the follow-up. Derivatives of intestinal microbiota, short-chain fatty acids, bile acids, and circulating metabolites derived from host intermediary metabolism will be assessed through metabolomics. Glucagon-like peptide 1 (GLP1) and gastric inhibitory polypeptide (GIP) dynamics after a standard meal test. Metagenomics. Bioenergetic analysis of PBMC by SeaHorse. Total EV miRNA profile. Isolation of host and bacterial EVs. Characterization of the protein cargo of host and bacterial EVs.

Eligibility

Inclusion Criteria:

  1. age between 18 and 70 years old.
  2. BMI ranges between 27 and 40 kg/ m2.
  3. Absence of underlying pathology in medical and physical examination, except for those related to excess weight.
  4. Signature of the informed consent for participation in the study.

Exclusion Criteria:

  1. Serious systemic disease not related to obesity, such as cancer, kidney or severe liver disease.
  2. Systemic diseases with intrinsic inflammatory activity (autoimmune diseases such as rheumatoid arthritis and asthma).
  3. Pregnancy and lactation.
  4. Vegetarians or subjects subjected to an irregular diet.
  5. Patients with severe eating disorders.
  6. Patients with clinical symptoms and signs of infection in the previous month.
  7. Patients with chronic anti-inflammatory steroid treatments and/or nonsteroidal anti-inflammatory drugs.
  8. Recent antibiotic treatment.
  9. Uncontrolled alcoholism or drug abuse.
  10. Rotating or nocturnal shift workers.

Study details
    Obesity

NCT06395246

Institut Investigacio Sanitaria Pere Virgili

16 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.